Medical Compression Systems (DBN) Ltd.

www.mcsmed.com

Now Pharmocann

High-Tech Company

Acquired by Zimmer Biomet

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	1997
Number of Employees	40

DESCRIPTION

Medical Compression Systems (MCS) is engaged in research, development, manufacturing and marketing of medical equipment in the fields of: orthopedics, vascular care and wound care. Based on its proprietary technology, the company has developed its ActiveCare DVT products line, featuring the ActiveCare DVT® and the ActiveCare+S.F.T. ® miniature mobile pneumatic compression systems. While traditional devices are restricted to mains use, the mobile ActiveCare products benefit from mains and battery operation.

Medical Compression Systems (MCS) is a leader in innovative, non-invasive solutions for the prevention of Deep Vein Thrombosis (DVT). The company is the first and currently the only to offer the healthcare market a new class of proven Continuous Enhanced Circulation Therapy in combination with MCS’s patented Synchronized Flow Technology (C.E.C.T.® + S.F.T.) devices, which can reduce the risk of bleeding complications, thus improving the standard health care.

TECHNOLOGY

MCS has designed and developed break-through proprietary Compression Therapy Platform technology that is the world’s first Continuous Enhanced Circulation Therapy (C.E.C.T.) system for the treatment of blood circulation problems.

The system incorporates a family of pneumatic compression devices that are unique in the way they create pressure and apply it to the patient's limbs. This highly efficient mode of operation has enabled the creation of miniature (palm-sized), totally mobile, battery-operated compression devices with unique hemodynamic properties that can be used continuously in a wide range of indications.

The special design of the limb sleeves of these new devices - which provide a unique state-of-the-art hemodynamic profile when inflated, as well as delivering an orthotic effect during the time they are deflated - effectively increases safety and efficacy in many clinical applications.

MCS has three registered patents for the first product of its Continuous Enhanced Circulation Therapy (C.E.C.T.) line, with another four patents pending for the new products in the pipeline.

Products and Phases

Product	Phase
The ActiveCast	FDA Approved
Bone fracture of the lower extremity is associated with post-traumatic pain and edema, impaired venous function, high risk for DVT and substantial risk for delayed healing and prolonged rehabilitation. The development of this new device has the potential to turn the standard stabilizing cast, which is a passive device, into an active system that will reduce posttraumatic edema and DVT and will enhance fracture healing and patient rehabilitation.
ActiveCare+SFT(R)	FDA Approved KFDA
ActiveCare+SFT is the only non-pharmaceutical, mechanical solution that provides effective prevention of Deep Vein Thrombosis (DVT) / Venous Thromboembolism (VTE) for in and out of hospital patient settings.

ESTIMATED ANNUAL SALES

Year	Amount
2016	500
2015	490
2014	480
2013	470
2011	460
2010	450
2009	440
2008	430
2007	420
2006	410
2005	400
2004	390
2003	380
2002	370

	TARGET MARKETS
	Hospitals, Vascular and Orthopedics Clinics.

	BUSINESS MODEL
	B2B

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm
abC Defghij	Accounting Firm

CONTACT INFO

Expand / Collapse All

Main Address: Or Akiva, Israel

Address	2 Hailan St., Or Akiva Industrial Park
POB	75
City	Or Akiva
Country	Israel
Zip	3060000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: West Hills, United States

Address	6520 Platt Ave. #804
City	West Hills
State/Province	CA
Country	United States
Zip	91307-3218

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Jacob Barak	Co-Founder
Mr. Adi Dagan	Co-Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

May. 04, 2017

Initial Revenues

abCDe

Following its acquisition, Medical Compression becoame a stock exchange shell. 12/2017: Cybele Investment House and ValueBase purchased control of the shell company. 12/2018: MSC shell company reversed merged with Pharmocann, and the company was renamed Pharmocann Glogal.

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	High-Tech Company	abCDe

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Nov. 02, 2009	Second Public Offering	TASE	abCDe	abCDe
May. 14, 2006	IPO	TASE	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Jan. 24, 2016

Initial Revenues

abCDe

PIPE

Feb. 24, 2015

Initial Revenues

abCDe

PIPE

Nov. 06, 2013

Initial Revenues

abCDe

PIPE

Sep. 01, 2013

Initial Revenues

abCDe

PIPE - Extended

Sep. 20, 2012

Initial Revenues

abCDe

PIPE

Aug. 13, 2012

Initial Revenues

abCDe

PIPE

Mar. 26, 2009

Initial Revenues

abCDe

PIPE

Dec. 01, 2008

Initial Revenues

abCDe

PIPE

Oct. 18, 2007

Initial Revenues

abCDe

Second Round

Dec. 24, 2003

Initial Revenues

abCDe

First Round - Extended

Jul. 01, 2001

R&D

abCDe

First Round

Jan. 30, 2001

R&D

abCDe

	PORTFOLIO COMPANIES

Historic Portfolio (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Pharmocann

Ceased to Operate

Agri

Reverse Merger

02/12/2018

N/A

Last Updated:	abCDe
IVC Number:	abCDe